These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The usefulness of prostate-specific antigen assay for the early detection and follow up of the prostate cancer]. Saito Y. Nihon Rinsho; 1998 Aug; 56(8):1989-93. PubMed ID: 9750493 [Abstract] [Full Text] [Related]
23. [Prostate specific antigen: a role of PSA in the diagnosis of prostate cancer]. Nutahara K, Higashihara E. Rinsho Byori; 2001 Oct; 49(10):963-6. PubMed ID: 11769472 [Abstract] [Full Text] [Related]
25. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies. Stephan C, Kramer J, Meyer HA, Kristiansen G, Ziemer S, Deger S, Lein M, Loening SA, Jung K. BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366 [Abstract] [Full Text] [Related]
28. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma. Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R. Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461 [Abstract] [Full Text] [Related]
31. [PSA-doubling time immediately before the diagnosis of prostate cancer]. Nakata S, Hasumi M, Suzuki T, Sato J, Imai K, Yamanaka H, Shimizu T. Hinyokika Kiyo; 1998 Feb 10; 44(2):81-4. PubMed ID: 9546125 [Abstract] [Full Text] [Related]
32. Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen. Nixon RG, Lilly JD, Liedtke RJ, Batjer JD. Arch Pathol Lab Med; 1997 Apr 10; 121(4):385-91. PubMed ID: 9140308 [Abstract] [Full Text] [Related]
33. Prospective evaluation of prostate cancer detection by prostate specific antigen related parameters: comparison in serum and plasma samples. Egawa S, Suyama K, Matsumoto K, Kuwao S, Baba S. J Urol; 2002 Jan 10; 167(1):97-102. PubMed ID: 11743284 [Abstract] [Full Text] [Related]
34. The variation of percent free prostate-specific antigen determined by two different assays. Yang CR, Ou YC, Horng YY, Lee HS. Anticancer Res; 2003 Jan 10; 23(1B):707-11. PubMed ID: 12680171 [Abstract] [Full Text] [Related]
35. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml. Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM. J Urol; 2002 Jan 10; 167(1):103-11. PubMed ID: 11743285 [Abstract] [Full Text] [Related]
40. [Clinical evaluation of TANDEM PSA in Japanese cases and comparison with other methods]. Kuriyama M, Yamamoto N, Shinoda I, Kawada Y, Akimoto S, Shimazaki J. Hinyokika Kiyo; 1995 Jan 10; 41(1):39-46. PubMed ID: 7534972 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]